sur InfusionPoints, LLC
InfusionPoints XBU40 Accelerates DoD IL4 Provisional Authorization for CoachMePlus and TIAG
InfusionPoints, LLC has announced the successful leveraging of its XBU40 platform to achieve a DoD IL4 Provisional Authorization (PA) for the CoachMePlus and TIAG Warrior Performance Platform (WP2). This development supports the U.S. Army's Holistic Health and Fitness Management System (H2FMS). The XBU40 platform utilizes cloud native services on AWS, combined with InfusionPoints' VNSOC360° managed services, to streamline the authorization process while minimizing preparation time and costs.
Senior Army leaders had sought a solution to consolidate Soldier health and fitness data. This led to the selection of the WP2 platform by the Army Applications Laboratory. WP2 aims to help Soldiers meet their health and fitness goals, while providing data to enhance overall readiness and well-being.
Teo Balbach, CEO of CoachMePlus, expressed enthusiasm about using data-driven decisions to improve Soldier training and performance. CoachMePlus and TIAG, both requiring a secure DoD-compliant platform, faced challenges such as team size and unfamiliarity with the authorization process.
Through the AWS Global Security and Compliance Acceleration (GSCA) program, InfusionPoints facilitated the integration of WP2 into the AWS GovCloud PaaS, XBU40. This expedited the time to authorization, resulting in both a DoD IL4 PA from DISA and an Interim Authority to Test (IATT) from the Army in March 2024.
Jackson Gorman, XBU40 Product Lead, highlighted that while typical DoD PA timelines span eighteen to twenty-four months, their team completed the process in fourteen months.
R. E.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de InfusionPoints, LLC